Screener
ADMA Biologics ADMA Plasma Collection Centers — General And Administrative Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| (in thousands) | ADMA Bio Manufacturing | Plasma Collection Centers | Total |
|---|---|---|---|
| Gain on sale of plasma centers | - | - | - |
| Selling, marketing and distribution | 7,634 | - | 7,634 |
| Depreciation and amortization expense | 1,281 | 499 | 1,780 |
| General and administrative expense | 8,340 | - | 8,340 |
| Other income (expense), net | (20) | 150 | 130 |
| Income (loss) before taxes | 64,010 | (707) | 63,303 |
| Expenditures for additions to long-lived assets | 2,256 | - | 2,256 |
| Total assets | 453,538 | 21,864 | 475,402 |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's plasma collection centers — general and administrative expense?
- ADMA Biologics (ADMA) reported plasma collection centers — general and administrative expense of $0 in Q2 2026.
- What does plasma collection centers — general and administrative expense mean?
- Covers the overhead costs associated with managing the plasma collection segment, including administrative staff, facility management, and compliance oversight. This metric helps evaluate the scalability of the segment's management structure. Lower G&A as a percentage of revenue indicates improved operational leverage.
Ask your AI about ADMA Biologics's plasma collection centers — general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude